JPWO2023150638A5 - - Google Patents
Info
- Publication number
- JPWO2023150638A5 JPWO2023150638A5 JP2024545962A JP2024545962A JPWO2023150638A5 JP WO2023150638 A5 JPWO2023150638 A5 JP WO2023150638A5 JP 2024545962 A JP2024545962 A JP 2024545962A JP 2024545962 A JP2024545962 A JP 2024545962A JP WO2023150638 A5 JPWO2023150638 A5 JP WO2023150638A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- adenoviral vector
- acid sequence
- cov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305979P | 2022-02-02 | 2022-02-02 | |
| US63/305,979 | 2022-02-02 | ||
| US202263375803P | 2022-09-15 | 2022-09-15 | |
| US63/375,803 | 2022-09-15 | ||
| US202263384075P | 2022-11-16 | 2022-11-16 | |
| US63/384,075 | 2022-11-16 | ||
| US202263434815P | 2022-12-22 | 2022-12-22 | |
| US63/434,815 | 2022-12-22 | ||
| PCT/US2023/061878 WO2023150638A2 (en) | 2022-02-02 | 2023-02-02 | Omicron coronavirus vaccine constructs and methods of making and using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508676A JP2025508676A (ja) | 2025-04-10 |
| JP2025508676A5 JP2025508676A5 (https=) | 2026-02-10 |
| JPWO2023150638A5 true JPWO2023150638A5 (https=) | 2026-02-10 |
Family
ID=87552962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545962A Pending JP2025508676A (ja) | 2022-02-02 | 2023-02-02 | オミクロンコロナウイルスワクチンコンストラクトならびにこれを作製および使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4473122A4 (https=) |
| JP (1) | JP2025508676A (https=) |
| KR (1) | KR20240137110A (https=) |
| CN (1) | CN120282795A (https=) |
| AU (1) | AU2023216258A1 (https=) |
| CA (1) | CA3243465A1 (https=) |
| WO (1) | WO2023150638A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250228929A1 (en) * | 2022-04-03 | 2025-07-17 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and immunogenic compositions for use in immunizing against sars-cov-2 omicron variant |
| CN116987184B (zh) * | 2023-09-26 | 2024-01-12 | 北京百普赛斯生物科技股份有限公司 | 新型冠状病毒bq.1.1突变株特异性抗体及其应用 |
| WO2025202543A1 (en) * | 2024-03-28 | 2025-10-02 | Rokote Laboratories Finland Oy | A vaccine composition comprising an adenoviral vector and an adenoviral vector delivery enhancing agent |
| WO2025250851A1 (en) * | 2024-05-29 | 2025-12-04 | Washington University | Trivalent pan-sarbecovirus mucosal vaccine constructs and methods of making and using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2716928C (en) * | 2008-03-04 | 2018-04-10 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof |
| CA3167833A1 (en) * | 2020-02-14 | 2021-08-19 | Bertrand Victor Gilbert GEORGES | Coronavirus immunogenic compositions and uses thereof |
| MX2022013934A (es) * | 2020-05-07 | 2023-02-22 | Icahn School Med Mount Sinai | Virus de la enfermedad de newcastle recombinante que expresa la proteina de espicula de sars-cov-2 y usos del mismo. |
| WO2021247567A1 (en) * | 2020-06-01 | 2021-12-09 | Washington University | Coronavirus vaccine constructs and methods of making and using same |
-
2023
- 2023-02-02 KR KR1020247029519A patent/KR20240137110A/ko active Pending
- 2023-02-02 CA CA3243465A patent/CA3243465A1/en active Pending
- 2023-02-02 CN CN202380033194.2A patent/CN120282795A/zh active Pending
- 2023-02-02 AU AU2023216258A patent/AU2023216258A1/en active Pending
- 2023-02-02 EP EP23750408.9A patent/EP4473122A4/en active Pending
- 2023-02-02 WO PCT/US2023/061878 patent/WO2023150638A2/en not_active Ceased
- 2023-02-02 JP JP2024545962A patent/JP2025508676A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8143054B2 (en) | Fusion protein of HIV regulatory/accessory proteins | |
| US20240123053A1 (en) | Coronavirus vaccine through nasal immunization | |
| US11253587B2 (en) | Vaccine compositions for the treatment of coronavirus | |
| WO2021220246A1 (en) | Recombinant sars-cov-2 polypeptides and uses | |
| TWI797603B (zh) | 免疫組合物 | |
| WO2023160654A1 (zh) | 一种可诱导广谱中和活性重组多组分新冠病毒三聚体蛋白疫苗的制备及应用 | |
| JPWO2023150638A5 (https=) | ||
| JP2003230396A (ja) | ｇｐ３５０／２２０非スプライシング変異体 | |
| JP2021518152A5 (https=) | ||
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| CN118119646A (zh) | 一种可诱导广谱中和活性重组五组分新冠病毒三聚体蛋白疫苗的制备及应用 | |
| WO2023047349A1 (en) | Stabilized coronavirus spike protein fusion proteins | |
| JPWO2021247567A5 (https=) | ||
| US20220233682A1 (en) | Vaccine compositions for the treatment of coronavirus | |
| US5430135A (en) | DNA sequence encoding a cynomolgus monkey hepatitis A virus capsid protein | |
| CN120815063A (zh) | 一种重组腺病毒载体疫苗制剂及其制备方法 | |
| JPWO2023057769A5 (https=) | ||
| CN119978138A (zh) | 包含冠状病毒的保守重组蛋白片段的疫苗组合物及其应用 | |
| RU2021128662A (ru) | Нуклеиновая кислота и вакцина против коронавируса с её использованием | |
| EP4282429A1 (en) | Multivalent covid-19 vaccines based on adenoviral vectors | |
| EP0904379A2 (en) | Simian-human hav having a chimeric 2c protein | |
| JPH03284628A (ja) | 牛疫ウイルスワクチン |